Although for various cancers, overexpression of efflux pumps is often associated with chemoresistance, deregulation of the PI3K/Akt/mTOR pathway contributes to the resistance of HCCs to drugs acting on microtubules, including vincristine, colchicine, and paclitaxel [32,33]. Here, AKT1 is linked to cancer.